Charles Schwab Investment Management Inc Akouos, Inc. Transaction History

Charles Schwab Investment Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.46 - $5.2 $133,892 - $283,025	-54,428 Reduced 83.59%	10,685 $51,000
Q4 2021 Feb 11, 2022	BUY	$7.65 - $11.38 $30,684 - $45,645	4,011 Added 6.56%	65,113 $554,000
Q3 2021 Nov 16, 2021	SELL	$9.93 - $13.59 $503,272 - $688,768	-50,682 Reduced 45.34%	61,102 $710,000
Q2 2021 Aug 16, 2021	SELL	$11.87 - $15.96 $75,089 - $100,962	-6,326 Reduced 5.36%	111,784 $1.4 Million
Q1 2021 May 17, 2021	BUY	$13.87 - $21.04 $335,029 - $508,221	24,155 Added 25.71%	118,110 $1.64 Million
Q4 2020 Feb 16, 2021	BUY	$17.03 - $22.45 $34,707 - $45,753	2,038 Added 2.22%	93,955 $1.86 Million
Q3 2020 Nov 13, 2020	BUY	$19.3 - $26.92 $1.77 Million - $2.47 Million	91,917 New	91,917 $2.1 Million

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.